Skip to main content
. 2024 Mar 10;13(17):2304626. doi: 10.1002/adhm.202304626

Figure 6.

Figure 6

Polymer‐based nanocarriers for ocular posterior drug delivery. a) The pharmacological treatment of wet AMD utilizing R@PCL‐T/M aims to concurrently mitigate oxidative stress, inflammation, and angiogenesis. Reproduced with permission.[ 100 ] Copyright 2023, American Chemical Society. b) The dendrimer‐triamcinolone acetonide conjugate exhibits promising potential in ameliorating CNV due to its unique macrophage/RPE targeting and anti‐inflammatory properties. Reproduced with permission.[ 101 ] Copyright 2021, Elsevier. c) The preparation of the Anti‐VEGF@BetP nanofiber hydrogel and its mechanism for treating CNV. Reproduced with permission.[ 102 ] Copyright 2023, Wiley‐VCH.